M. R. Hamczyk, L. Del-campo, and V. Andrés, Aging in the Cardiovascular System: Lessons from Hutchinson-Gilford Progeria Syndrome, Annual Review of Physiology, vol.80, issue.1, pp.27-48, 2018.

G. S. Bleumink, A. M. Knetsch, M. C. Sturkenboom, S. M. Straus, A. Hofman et al., European Heart Journal, vol.25, issue.18, pp.1614-1619, 2004.

N. Conrad, A. Judge, J. Tran, H. Mohseni, D. Hedgecott et al., Temporal trends and patterns in heart failure incidence: a population-based study of 4 million individuals, The Lancet, vol.391, issue.10120, pp.572-580, 2018.

V. Lazzarini, R. J. Mentz, M. Fiuzat, M. Metra, and C. M. O'connor, Heart failure in elderly patients: distinctive features and unresolved issues, European Journal of Heart Failure, vol.15, issue.7, pp.717-723, 2013.

S. Laurent, P. Boutouyrie, P. G. Cunha, P. Lacolley, and P. M. Nilsson, Concept of Extremes in Vascular Aging, Hypertension, vol.74, issue.2, pp.218-228, 2019.

J. Jylhava, N. L. Pedersen, and S. Hagg, Biological Age Predictors, vol.21, pp.29-36, 2017.

A. A. Voors, W. Ouwerkerk, F. Zannad, D. J. Van-veldhuisen, N. J. Samani et al., Development and validation of multivariable models to predict mortality and hospitalization in patients with heart failure, European Journal of Heart Failure, vol.19, issue.5, pp.627-634, 2017.

M. R. Hamczyk, R. M. Nevado, A. Barettino, V. Fuster, and V. Andrés, Biological Versus Chronological Aging, Journal of the American College of Cardiology, vol.75, issue.8, pp.919-930, 2020.

A. A. Voors, S. D. Anker, J. G. Cleland, K. Dickstein, G. Filippatos et al., A systems BIOlogy Study to TAilored Treatment in Chronic Heart Failure: rationale, design, and baseline characteristics of BIOSTAT-CHF, European Journal of Heart Failure, vol.18, issue.6, pp.716-726, 2016.

J. J. Mcmurray, S. Adamopoulos, S. D. Anker, A. Auricchio, M. Bohm et al., ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC, European Heart Journal, vol.33, issue.14, pp.1787-1847, 2012.

G. H. Green and P. J. Diggle, On the Operational Characteristics of the Benjamini and Hochberg False Discovery Rate Procedure, Statistical Applications in Genetics and Molecular Biology, vol.6, issue.1, p.27, 2007.

I. E. Sama, R. J. Woolley, J. F. Nauta, S. P. Romaine, J. Tromp et al., A network analysis to identify pathophysiological pathways distinguishing ischaemic from non?ischaemic heart failure, European Journal of Heart Failure, vol.22, issue.5, pp.821-833, 2020.

P. Shannon, A. Markiel, O. Ozier, N. S. Baliga, J. T. Wang et al., Cytoscape: A Software Environment for Integrated Models of Biomolecular Interaction Networks, Genome Research, vol.13, issue.11, pp.2498-2504, 2003.

C. López-otín, M. A. Blasco, L. Partridge, M. Serrano, and G. Kroemer, The Hallmarks of Aging, Cell, vol.153, issue.6, pp.1194-1217, 2013.

F. Triposkiadis, A. Xanthopoulos, and J. Butler, Cardiovascular Aging and Heart Failure, Journal of the American College of Cardiology, vol.74, issue.6, pp.804-813, 2019.

J. P. Aboumsallem, J. Moslehi, R. A. De-boer, R. A. De-boer, W. C. Meijers et al., Reverse Cardio-Oncology: Cancer Development in Patients With Cardiovascular Disease, J Am Heart Assoc, vol.2020, issue.2, pp.1515-1525, 2019.

W. C. Meijers and R. A. De-boer, Common risk factors for heart failure and cancer, Cardiovascular Research, vol.115, issue.5, pp.844-853, 2019.

W. C. Meijers, M. Maglione, S. J. Bakker, R. Oberhuber, L. M. Kieneker et al., Heart Failure Stimulates Tumor Growth by Circulating Factors, Circulation, vol.138, issue.7, pp.678-691, 2018.

N. E. Hynes and D. F. Stern, The biology of erbB-2/nue/HER-2 and its role in cancer, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, vol.1198, issue.2-3, pp.165-184, 1994.

Z. Vermeulen, V. F. Segers, and G. W. De-keulenaer, ErbB2 signaling at the crossing between heart failure and cancer, Basic Research in Cardiology, vol.111, issue.6, p.60, 2016.

E. M. Braunstein, R. Li, N. Sobreira, B. Marosy, K. Hetrick et al., A germline ERBB3 variant is a candidate for predisposition to erythroid MDS/erythroleukemia, Leukemia, vol.30, issue.11, pp.2242-2245, 2016.

W. Liu, L. Tang, G. Zhang, H. Wei, Y. Cui et al., Characterization of a Novel C-type Lectin-like Gene, LSECtin, Journal of Biological Chemistry, vol.279, issue.18, pp.18748-18758, 2004.

E. G. Lakatta, Arterial and Cardiac Aging: Major Shareholders in Cardiovascular Disease Enterprises, Circulation, vol.107, issue.3, pp.490-497, 2003.

Y. Chen, L. Huang, S. Wang, T. Liu, Y. Wu et al., WAP four-disulfide core domain protein 2 promotes metastasis of human ovarian cancer by regulation of metastasis-associated genes, Journal of Ovarian Research, vol.10, issue.1, p.40, 2017.

K. Parikh, A. Antanaviciute, D. Fawkner-corbett, M. Jagielowicz, A. Aulicino et al., Colonic epithelial cell diversity in health and inflammatory bowel disease, Nature, vol.567, issue.7746, pp.49-55, 2019.

L. E. Zheng, J. Y. Qu, F. He, R. A. De-boer, Q. Cao et al., The diagnosis and pathological value of combined detection of HE4 and CA125 for patients with ovarian cancer, Open Med (Wars), vol.2016, issue.1, pp.164-173

A. Bouchon, J. Dietrich, M. E. Colonna, I. Daissormont, M. Aslani et al., Cutting edge: inflammatory responses can be triggered by TREM-1, a novel receptor expressed on neutrophils and monocytes, Interruption of the CXCL13/CXCR5 Chemokine Axis Enhances Plasma IgM Levels and Attenuates Atherosclerosis Development, vol.164, pp.344-347, 2000.

L. M. Smedbakken, B. Halvorsen, I. Daissormont, T. Ranheim, A. E. Michelsen et al., Increased levels of the homeostatic chemokine CXCL13 in human atherosclerosis ? Potential role in plaque stabilization, Atherosclerosis, vol.224, issue.1, pp.266-273, 2012.

, Table 4: KEGG annotations of enriched pathways., These three resources were updated on 26-March-2020 before the analyses

, Supplementary file 1. Genes that are up-regulated (UP) and down-regulated (DOWN) Dnmt3a vs.

?. , Supplementary file 1. Genes that are up-regulated (UP) and down-regulated (DOWN) Dnmt3a vs.

, Heart Failure with Reduced Ejection Fraction (HFrEF), Encyclopedia of Behavioral Medicine, pp.1047-1047, 2020.

T. H. Cao, What is the added value of the waist-to-hip ratio on top of the BIOSTAT-CHF risk prediction model in patients with heart failure?, European Journal of Heart Failure, vol.21, issue.1, pp.132-132, 2018.